Navigation Links
Sanovia Selected to Deliver PA-Logic(TM) Pharmaceutical Prior Authorization Platform to HealthSpring

PHILADELPHIA, Oct. 21 /PRNewswire/ -- Sanovia, a leading provider of pharmacy utilization management solutions, today announced that it has been selected by HealthSpring, Inc. to deliver its PA-Logic(TM) pharmaceutical prior authorization platform to HealthSpring, one of the largest Medicare Advantage coordinated care plans in the U.S. The selection reinforces Sanovia's leadership in delivering pharmaceutical prior authorization solutions that help its customers drive down administrative costs and drug spend by automating the prior authorization process for high cost pharmaceuticals including specialty drugs and injectibles.

(Logo: )

HealthSpring will deploy Sanovia's web based PA-Logic(TM) to automate the prior authorizations for its Medicare Advantage and standalone prescription drug plan members. By automating a traditionally manual process, HealthSpring will more efficiently manage their pharmaceutical prior authorization process. The improvements brought by PA-Logic(TM)'s automated clinical pathways mean a marked improvement in processing turn-around time, consistency of decision making, and quality of the decisions being rendered. PA-Logic(TM) gives HealthSpring a comprehensive solution automating the entire pharmaceutical prior authorization process, from initial request to decision. Ultimately, PA-Logic(TM) will allow HealthSpring to ensure that its members are receiving the right drug, at the right time and at the right dose, while significantly reducing turn-around time and cost, and improving quality.

"We are delighted to count HealthSpring among our growing list of customers. HealthSpring's selection of our PA-Logic(TM) pharmaceutical management product demonstrates their recognition that Sanovia's products will help them to continue to deliver on their goal of healthier members with lower medical costs," said Robert E. Tremain, President and CEO of Sanovia.

About PA-Logic(TM)

Sanovia's PA-Logic(TM) is a web based solution that automates the pharmaceutical prior authorization process. PA-Logic(TM) uses best-practice clinical guidelines to evaluate pharmaceutical requests, ensure adherence to benefit designs and enable appropriate decisions when requests are made. By combining automation with clinical best practices, PA-Logic(TM) gives its healthplan and Pharmacy Benefit Manager (PBM) customers greater control and consistency in decision making, while driving down administrative costs and drug spend. The system manages and automates the pharmacy review process on an electronic platform, which reduces slow and error-prone paper-based methods, speeds routing of information and accelerates decisions to help prevent treatment delays. Plans can also allow their participating providers to access the system from their offices via the Internet, and submit requests electronically, thus eliminating the frustration of dealing with paper forms, phone calls, faxes and returns for incomplete information. PA-Logic(TM)'s letter writer and report generator functions automate workflow, produce real-time reports on pharmacy program operations and facilitate communications with patients and physicians.

About Sanovia Corporation

Sanovia is a leading provider of pharmacy utilization management solutions. Sanovia integrates smart business practices with automated decision-making technology and best-practice clinical guidelines, delivering proven savings in administrative costs and pharmaceutical spending for managed care companies and PBM's.

Sanovia's portfolio of innovative products and services meet the increasing challenges of pharmaceutical administration, validation, documentation, utilization, cost and workflow management. Clients use Sanovia's "intelligent" clinical decision support products to balance pharmaceutical cost management with appropriateness of therapy and quality of care. Sanovia is privately held and venture-backed, with no ownership by any pharmacy benefit manager, health plan or pharmaceutical manufacturer. Headquartered in Philadelphia, Sanovia can be reached at 610-521-2211 or at

SOURCE Sanovia Corporation

SOURCE Sanovia Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. A Unique Endoluminal Approach for the Treatment of Morbid Obesity Selected for Presentation at the 2009 American College of Surgeons Clinical Congress
2. Fresenius Medical Care, N.A. Has Selected VitalRemedyMDs VitalProteinRx(TM) As Its Bar of Choice for Protein Replacement in Dialysis Patients
3. Sangamo BioSciences Announces Research Collaboration With UCLA in Human Stem Cells Selected to Receive Clinical Research Award
4. Keryx Biopharmaceuticals Phase 2 Data of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Renal Cell Cancer Selected for Oral Presentation at the Eighth International Kidney Cancer Symposium
5. Jennerex Therapeutic Research Collaboration With Ottawa Hospital Research Institute Selected for $10 Million Grant From Ontario Institute for Cancer Research
6. Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program
7. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation
8. XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention
9. Cepheid GeneXpert(R) System and Xpert(TM) MRSA Selected for up to 11 Victoria, Australia Hospitals in Rollout of Start Clean Strategy
10. Caliper Life Sciences Optical Imaging Technology Selected to Aid Tuberculosis Research Efforts by the Texas A&M Health Science Center
11. GeoVax Labs, Inc. Selected by Georgia Bio as 2008 Deal of the Year Award Winner in Life Sciences Industry
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015 ... the addition of the "Global Brain ... their offering. --> ) ... "Global Brain Monitoring Devices Market 2015-2019" ... Research and Markets ( ) has ...
(Date:11/25/2015)... THOUSAND OAKS, Calif. , Nov. 25, 2015 /PRNewswire/ ... of a Biologics License Application (BLA) with ... Administration (FDA) for ABP 501, a biosimilar candidate to ... the first adalimumab biosimilar application submitted to the FDA ... biosimilar pathway. Sean E. Harper , M.D., ...
(Date:11/25/2015)... WOODBURY, N.Y. , Nov. 25, 2015  Linden ... access and optimizing treatment outcomes for patients suffering from ... its request for a Temporary Restraining Order (TRO) enjoining ... between the two companies. --> ... aggressively pursuing all of its legal options. ...
Breaking Medicine Technology:
(Date:11/28/2015)... ... November 28, 2015 , ... Safe storage for contraceptive ... two inventors, one from Lakewood, New Jersey and the other from Bradley Beach, New ... PROTECTOR to save the expense of having to replace NuvaRings more often than necessary. ...
(Date:11/27/2015)... Canada (PRWEB) , ... November 28, 2015 , ... There ... do we outperform our billings from last year? , This question has not been ... organizations are coming to the retirement age and the younger workforce don’t share the ...
(Date:11/27/2015)... ... November 27, 2015 , ... The rapid speed at which ... age, more care is needed, especially with Alzheimer’s, dementia and other cognitive conditions ... overworked. The forgotten part of this equation: 80 percent of medical care occurs ...
(Date:11/27/2015)... ... 27, 2015 , ... Lizzie’s Lice Pickers just announced a special promotion that ... of their purchase of lice treatment product. In addition, customers will receive a complimentary ... spokesperson. “Finding lice is a sure way to ruin the holidays, so we encourage ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... through sharing, the 2016 Building Better Radiology Marketing Programs meeting will ... on Sunday, March 6, 2016, at Caesars Palace in Las Vegas with a ...
Breaking Medicine News(10 mins):